Coronado Industries Projects Potential Earnings From Sales of PNT Equipment.

Business Editors

FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--Jan. 11, 2000

Coronado Industries, Inc. (OTC BB: CDIK), a manufacturer of proprietary pneumatic devices for the effective treatment of glaucoma, today announced projected earnings based on the sale, pending FDA approval, of its PNT(tm) equipment and patented disposable ring.

Coronado President Gary Smith commented, "Upon FDA approval, we will market our equipment to a minimum sales base of 50,000 doctors, comprised of 32,000 optometrists and 18,000 ophthalmologists, just in the United States alone. If we can sell only 1 out of every 10 doctors, a total of 5,000 doctors, we will realize $72,500,000 in gross revenues from equipment sales."

In addition to sales in the United States, an even larger potential market exists in China, Europe, and other parts of the world. Glaucoma, the disease treated by PNT, afflicts nearly 66 million people worldwide.

Smith continued, "In addition to revenues from the initial sale, yearly revenues of $62,500,000 in sales of the disposable ring would be generated to support the equipment in the field."

Gary Smith concluded, "We at Coronado Industries, Inc. are confident that our PNT equipment will soon become a standard piece of equipment in any doctor's office, much like today's microscope. We also believe that PNT will become the first line of treatment for glaucoma, because of its effectiveness in clinical tests, and the apparent absence of side effects."

Coronado Industries, through its wholly owned subsidiaries American Glaucoma and Opthalmic International, has developed and tested the patented procedure Pneumatic Trabeculoplasty (PNT(tm)), a non-invasive, highly effective, and low-cost alternative to traditional treatments. Currently, the Company's pneumatic suction device and treatment are available throughout the European marketplace. Coronado awaits FDA approval, upon which it will license its patented treatment procedure and equipment in the United States.

For additional information, see www.coronadoindustries.com

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.